Lo Andrew
BridgeBio Pharma, Inc. - Common Stock · Director
Lo Andrew is listed in filings as Director at BridgeBio Pharma, Inc. - Common Stock. This profile follows SEC Form 4 activity through Nov 19, 2025, including sale activity. Recent filings connect the profile to BridgeBio Pharma, Inc. - Common Stock (BBIO) and AbCellera Biologics Inc. (ABCL). The current snapshot covers public activity from Jun 24, 2024 to Nov 19, 2025. Reported amounts are shown as $3.8M to $254.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $4M100k shares | SellMay 2, 2025 | $38.50 | $81.46 | |
| $255k3.8k shares | SellNov 17, 2025 | $67.06 | $81.46 | |
| $2M36.8k shares | SellNov 17, 2025 | $66.63 | $81.46 |